Hiroaki Ohno

Title: Hiroaki Ohno: Innovator in Quinoline and Quinazoline Derivatives

Introduction

Hiroaki Ohno is a notable inventor based in Takasaki, Japan. He has made significant contributions to the field of chemistry, particularly in the development of compounds that inhibit autophosphorylation of macrophage colony-stimulating factor receptors. His work has implications for various medical applications.

Latest Patents

Hiroaki Ohno holds a patent for "Quinoline derivatives and quinazoline derivatives inhibiting autophosphorylation of macrophage colony stimulating factor receptor." The objective of this invention is to provide compounds that exhibit inhibitory activity against the autophosphorylation of macrophage colony-stimulating factor receptors. The compounds are represented by a specific formula, which includes various substituents that enhance their effectiveness.

Career Highlights

Ohno is currently associated with Kirin Beer Kabushiki Kaisha, where he continues to innovate and contribute to the field. His work has garnered attention for its potential applications in therapeutic settings.

Collaborations

Hiroaki Ohno has collaborated with notable colleagues such as Kazuo Kubo and Toshiyuki Isoe. These partnerships have fostered a collaborative environment that enhances the research and development of innovative compounds.

Conclusion

Hiroaki Ohno's contributions to the field of chemistry, particularly through his patent on quinoline and quinazoline derivatives, highlight his role as an influential inventor. His work continues to pave the way for advancements in medical research and applications.